Links

Tools

Export citation

Search in Google Scholar

Outcome following alemtuzumab (CAMPATH-1H) containing reduced intensity allogeneic transplant regimen for relapsed and refractory Non-Hodgkin's Lymphoma (NHL).

Journal article published in 2005 by Emma C. Morris ORCID, S. Mackinnon
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload